Neurogene Stock Price History
NGNE Stock | 16.75 0.05 0.30% |
Below is the normalized historical share price chart for Neurogene extending back to March 07, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurogene stands at 16.75, as last reported on the 17th of March 2025, with the highest price reaching 17.24 and the lowest price hitting 16.46 during the day.
If you're considering investing in Neurogene Stock, it is important to understand the factors that can impact its price. Neurogene has Sharpe Ratio of -0.0949, which conveys that the firm had a -0.0949 % return per unit of risk over the last 3 months. Neurogene exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurogene's Risk Adjusted Performance of (0.07), mean deviation of 3.62, and Standard Deviation of 4.89 to check out the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 175.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 14 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.19, whereas Price To Sales Ratio is forecasted to decline to 32.51. Neurogene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of March 2014 | 200 Day MA 38.9992 | 50 Day MA 46.9117 |
Neurogene |
Sharpe Ratio = -0.0949
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NGNE |
Estimated Market Risk
4.91 actual daily | 43 57% of assets are more volatile |
Expected Return
-0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neurogene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurogene by adding Neurogene to a well-diversified portfolio.
Price Book 1.801 | Enterprise Value Ebitda (8.02) | Price Sales 268.1876 | Shares Float 4.1 M | Wall Street Target Price 54.6 |
Neurogene Stock Price History Chart
There are several ways to analyze Neurogene Stock price data. The simplest method is using a basic Neurogene candlestick price chart, which shows Neurogene price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 26, 2024 | 24.1 |
Lowest Price | January 24, 2025 | 15.06 |
Neurogene March 17, 2025 Stock Price Synopsis
Various analyses of Neurogene's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurogene Stock. It can be used to describe the percentage change in the price of Neurogene from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurogene Stock.Neurogene Price Action Indicator | (0.07) | |
Neurogene Price Daily Balance Of Power | 0.06 | |
Neurogene Price Rate Of Daily Change | 1.00 |
Neurogene March 17, 2025 Stock Price Analysis
Neurogene Stock Price History Data
The price series of Neurogene for the period between Tue, Dec 17, 2024 and Mon, Mar 17, 2025 has a statistical range of 10.07 with a coefficient of variation of 15.5. The daily prices for the period are spread out with arithmetic mean of 19.26. The median price for the last 90 days is 18.08. The company underwent 1:4 stock split on 19th of December 2023.Open | High | Low | Close | Volume | ||
03/17/2025 | 16.70 | 17.24 | 16.46 | 16.75 | ||
03/17/2025 | 16.70 | 17.24 | 16.46 | 16.75 | ||
03/14/2025 | 17.13 | 17.24 | 16.46 | 16.70 | 221,389 | |
03/13/2025 | 17.85 | 17.89 | 16.36 | 16.80 | 147,380 | |
03/12/2025 | 18.12 | 18.62 | 17.45 | 17.78 | 119,358 | |
03/11/2025 | 17.06 | 17.93 | 16.76 | 17.67 | 217,546 | |
03/10/2025 | 17.02 | 17.40 | 16.65 | 17.05 | 127,281 | |
03/07/2025 | 16.80 | 17.48 | 16.44 | 17.28 | 76,721 | |
03/06/2025 | 16.61 | 16.99 | 16.24 | 16.75 | 649,953 | |
03/05/2025 | 16.10 | 17.31 | 16.08 | 16.91 | 88,912 | |
03/04/2025 | 16.03 | 16.51 | 15.69 | 16.35 | 144,890 | |
03/03/2025 | 17.78 | 17.78 | 16.20 | 16.21 | 170,058 | |
02/28/2025 | 17.18 | 17.77 | 16.54 | 17.69 | 59,465 | |
02/27/2025 | 17.20 | 17.70 | 16.73 | 17.10 | 202,599 | |
02/26/2025 | 16.80 | 17.31 | 16.65 | 17.20 | 126,883 | |
02/25/2025 | 16.45 | 16.93 | 16.04 | 16.76 | 205,083 | |
02/24/2025 | 16.75 | 17.54 | 16.52 | 16.60 | 182,626 | |
02/21/2025 | 17.53 | 17.91 | 16.95 | 17.36 | 137,367 | |
02/20/2025 | 16.89 | 17.55 | 16.72 | 17.31 | 120,236 | |
02/19/2025 | 17.07 | 17.80 | 16.96 | 16.97 | 242,710 | |
02/18/2025 | 18.42 | 19.35 | 16.95 | 17.35 | 141,355 | |
02/14/2025 | 18.75 | 19.97 | 18.09 | 18.42 | 102,861 | |
02/13/2025 | 18.65 | 19.48 | 18.24 | 18.77 | 133,081 | |
02/12/2025 | 17.31 | 18.61 | 17.31 | 18.57 | 100,263 | |
02/11/2025 | 18.33 | 18.90 | 17.17 | 17.79 | 157,016 | |
02/10/2025 | 20.77 | 20.95 | 17.73 | 18.89 | 301,383 | |
02/07/2025 | 23.06 | 23.70 | 19.82 | 20.46 | 314,540 | |
02/06/2025 | 21.51 | 26.48 | 20.96 | 23.30 | 1,018,893 | |
02/05/2025 | 18.07 | 23.73 | 17.64 | 21.53 | 816,739 | |
02/04/2025 | 16.88 | 18.33 | 16.88 | 18.08 | 173,370 | |
02/03/2025 | 15.25 | 17.28 | 15.16 | 16.84 | 211,246 | |
01/31/2025 | 15.57 | 16.33 | 15.21 | 15.85 | 329,047 | |
01/30/2025 | 15.53 | 16.70 | 15.51 | 15.53 | 219,345 | |
01/29/2025 | 15.41 | 15.88 | 15.25 | 15.51 | 137,543 | |
01/28/2025 | 15.00 | 15.62 | 14.54 | 15.48 | 186,768 | |
01/27/2025 | 14.82 | 16.29 | 14.78 | 15.08 | 241,953 | |
01/24/2025 | 15.45 | 15.63 | 14.42 | 15.06 | 472,026 | |
01/23/2025 | 15.86 | 16.12 | 15.33 | 15.58 | 267,446 | |
01/22/2025 | 16.31 | 16.85 | 15.92 | 15.95 | 135,647 | |
01/21/2025 | 16.69 | 16.98 | 16.00 | 16.62 | 202,068 | |
01/17/2025 | 17.60 | 17.75 | 16.14 | 16.60 | 159,375 | |
01/16/2025 | 18.43 | 18.48 | 17.50 | 17.63 | 149,520 | |
01/15/2025 | 18.59 | 19.14 | 18.15 | 18.54 | 85,442 | |
01/14/2025 | 19.07 | 20.29 | 17.63 | 17.89 | 282,899 | |
01/13/2025 | 19.10 | 19.32 | 17.91 | 18.81 | 229,750 | |
01/10/2025 | 20.85 | 20.85 | 19.27 | 19.58 | 190,600 | |
01/08/2025 | 21.63 | 22.23 | 20.65 | 21.49 | 165,671 | |
01/07/2025 | 22.59 | 23.62 | 21.44 | 21.86 | 202,952 | |
01/06/2025 | 23.31 | 24.00 | 22.90 | 23.12 | 218,471 | |
01/03/2025 | 22.91 | 23.80 | 22.64 | 23.23 | 193,336 | |
01/02/2025 | 23.49 | 23.84 | 22.44 | 22.89 | 277,990 | |
12/31/2024 | 22.60 | 23.37 | 21.33 | 22.86 | 349,429 | |
12/30/2024 | 22.19 | 22.54 | 21.29 | 22.28 | 253,689 | |
12/27/2024 | 24.83 | 24.83 | 22.96 | 22.97 | 158,662 | |
12/26/2024 | 23.32 | 24.84 | 23.01 | 24.10 | 217,217 | |
12/24/2024 | 22.27 | 22.85 | 22.03 | 22.62 | 76,117 | |
12/23/2024 | 22.65 | 22.92 | 21.99 | 22.50 | 184,450 | |
12/20/2024 | 21.78 | 23.89 | 21.51 | 22.64 | 466,317 | |
12/19/2024 | 22.02 | 23.20 | 21.34 | 22.08 | 299,837 | |
12/18/2024 | 23.97 | 24.02 | 21.68 | 21.79 | 303,613 | |
12/17/2024 | 24.74 | 25.35 | 22.92 | 23.72 | 296,478 |
About Neurogene Stock history
Neurogene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurogene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurogene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurogene stock prices may prove useful in developing a viable investing in Neurogene
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 14.7 M | 14 M |
Neurogene Quarterly Net Working Capital |
|
Neurogene Stock Technical Analysis
Neurogene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
Neurogene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Neurogene's price direction in advance. Along with the technical and fundamental analysis of Neurogene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurogene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.27) | |||
Total Risk Alpha | 0.1886 | |||
Treynor Ratio | (0.30) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Neurogene Stock analysis
When running Neurogene's price analysis, check to measure Neurogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurogene is operating at the current time. Most of Neurogene's value examination focuses on studying past and present price action to predict the probability of Neurogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurogene's price. Additionally, you may evaluate how the addition of Neurogene to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |